H. Lode

11.5k total citations · 1 hit paper
277 papers, 8.3k citations indexed

About

H. Lode is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, H. Lode has authored 277 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Epidemiology, 117 papers in Pharmacology and 60 papers in Molecular Medicine. Recurrent topics in H. Lode's work include Antibiotics Pharmacokinetics and Efficacy (113 papers), Pneumonia and Respiratory Infections (102 papers) and Antibiotic Resistance in Bacteria (60 papers). H. Lode is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (113 papers), Pneumonia and Respiratory Infections (102 papers) and Antibiotic Resistance in Bacteria (60 papers). H. Lode collaborates with scholars based in Germany, United States and United Kingdom. H. Lode's co-authors include Ralf Stahlmann, P. Koeppe, T. Schaberg, K. Börner, A de Roux, G. Höffken, H. Mauch, Mathias W. Pletz, David W. Denning and Klaus Borner and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

H. Lode

260 papers receiving 7.7k citations

Hit Papers

Efficacy and Safety of Voriconazole in the Treatment of A... 2002 2026 2010 2018 2002 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Lode Germany 48 4.1k 2.5k 2.3k 1.3k 1.2k 277 8.3k
Javier Garau Spain 53 4.8k 1.2× 1.4k 0.6× 2.3k 1.0× 1.9k 1.5× 2.2k 1.9× 208 10.9k
Mike Sharland United Kingdom 58 4.9k 1.2× 1.6k 0.7× 2.4k 1.0× 1.2k 0.9× 1.3k 1.1× 367 11.5k
Francesc Gudiol Spain 56 5.2k 1.3× 1.2k 0.5× 2.5k 1.1× 997 0.8× 1.7k 1.5× 176 9.5k
George Dimοpoulos Greece 53 4.6k 1.1× 2.0k 0.8× 3.7k 1.6× 1.4k 1.1× 1.6k 1.4× 199 8.8k
Keith A. Rodvold United States 51 3.2k 0.8× 4.9k 2.0× 3.7k 1.6× 713 0.5× 2.2k 1.9× 186 10.2k
Gary V. Doern United States 62 7.5k 1.8× 2.3k 0.9× 4.4k 1.9× 1.3k 1.0× 3.2k 2.7× 237 13.6k
José Garnacho‐Montero Spain 53 4.7k 1.1× 1.6k 0.6× 2.6k 1.1× 1.1k 0.8× 2.4k 2.0× 189 9.4k
W. Michael Scheld United States 40 3.8k 0.9× 1.0k 0.4× 1.6k 0.7× 448 0.3× 1.2k 1.0× 102 8.6k
Philippe Montravers France 47 2.9k 0.7× 1.2k 0.5× 2.0k 0.9× 1.3k 1.0× 1.0k 0.9× 254 7.7k
Mario Venditti Italy 54 4.3k 1.1× 1.2k 0.5× 3.8k 1.7× 532 0.4× 2.2k 1.9× 281 9.7k

Countries citing papers authored by H. Lode

Since Specialization
Citations

This map shows the geographic impact of H. Lode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lode more than expected).

Fields of papers citing papers by H. Lode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Lode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lode. The network helps show where H. Lode may publish in the future.

Co-authorship network of co-authors of H. Lode

This figure shows the co-authorship network connecting the top 25 collaborators of H. Lode. A scholar is included among the top collaborators of H. Lode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Lode. H. Lode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ludwig, Endre, Serhat Ünal, Miron Alexandru Bogdan, et al.. (2012). Opportunity for Healthy Ageing: Lessening the Burden of Adult Pneumococcal Disease in Central and Eastern Europe, and Israel. Central European Journal of Public Health. 20(2). 121–125. 5 indexed citations
2.
Rello, Jordi, et al.. (2010). A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Medicine. 36(5). 773–780. 162 indexed citations
3.
Lode, H.. (2009). Clinical impact of antibiotic-resistant Gram-positive pathogens. Clinical Microbiology and Infection. 15(3). 212–217. 72 indexed citations
4.
Schaberg, T. & H. Lode. (2008). Diagnostik der nosokomialen Pneumonie*. DMW - Deutsche Medizinische Wochenschrift. 122(3). 61–64.
5.
Sendzik, Judith, H. Lode, & Ralf Stahlmann. (2008). Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data. International Journal of Antimicrobial Agents. 33(3). 194–200. 74 indexed citations
6.
Raffenberg, M., et al.. (2008). Indikation und Praxis der Heimbeatmung. DMW - Deutsche Medizinische Wochenschrift. 119(6). 187–191.
7.
Marx, A, Olaf Burkhardt, Brunhilde Schweiger, et al.. (2005). Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine. 24(10). 1537–1542. 41 indexed citations
8.
Roux, A de, Norman B. Schmidt, Markus A. Rose, et al.. (2004). Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids. Respiratory Medicine. 98(12). 1187–1194. 35 indexed citations
9.
Lode, H., et al.. (2004). A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia. Clinical Microbiology and Infection. 10(5). 403–408. 10 indexed citations
10.
Lode, H., et al.. (2004). A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia. Clinical Microbiology and Infection. 10(5). 403–408. 2 indexed citations
11.
Lode, H.. (2001). Antimicrobial Resistance Among. Journal watch. 2001. 6 indexed citations
12.
Lode, H., J Eller, M. Raffenberg, & H. Mauch. (2000). Role of long-acting cephalosporins in the treatment of lower respiratory tract infections. Clinical Microbiology and Infection. 6. 87–89. 1 indexed citations
13.
Worth, H., Dieter Adam, Werner Handrick, et al.. (1997). Prophylaxe und Therapie von bronchialen Infektionen: Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 92(12). 699–704. 3 indexed citations
14.
Wolff, Michel, Christian Brun‐Buisson, H. Lode, et al.. (1997). The changing epidemiology of severe infections in the ICU. Clinical Microbiology and Infection. 3. S36–S47. 28 indexed citations
15.
Lode, H., et al.. (1996). Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leukocytes and saliva. Clinical Microbiology and Infection. 1(4). 235–243. 12 indexed citations
16.
Schaberg, T., et al.. (1995). Subpopulations of Alveolar Macrophages in Smokers and Nonsmokers: Relation to the Expression of CD11/CD18 Molecules and Superoxide Anion Production. American Journal of Respiratory and Critical Care Medicine. 151(5). 1551–1558. 42 indexed citations
17.
Lode, H., P Periti, & C.J.L. Strachan. (1985). Cefotetan : a long-acting antibiotic. Churchill Livingstone eBooks. 7 indexed citations
19.
Dalhoff, A., et al.. (1982). Pharmacokinetics and Antibacterial Efficacy in vivo of Beta-Lactam Combinations against <i>Proteus vulgaris</i>. Chemotherapy. 28(6). 444–453. 3 indexed citations
20.
Oswald, P., et al.. (1971). Changes in pulmonary function of young people as a result of cigarette smoking over many years.. DMW - Deutsche Medizinische Wochenschrift. 96(46). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026